Interview

Commure CEO Tanay Tandon on merging Athelas and Commure to automate healthcare administration with AI

Jun 19, 2025 with Tanay Tandon

Key Points

  • Commure closes $200 million funding round at $6 billion valuation, positioning AI workflow automation as the antidote to U.S. hospital systems running on razor-thin 1 to 3% operating margins.
  • The merger of Athelas and Commure creates a platform targeting the full healthcare administrative stack, from clinical documentation to claims processing, with ambitions to absorb narrower point solutions the way Epic dominates EMRs.
  • General Catalyst's acquisition of Summa Health, a 20-facility Ohio hospital system, serves as the venture firm's thesis test: LLMs can structurally improve hospital margins while eliminating tens of thousands of administrative jobs consumed by insurer-driven claim friction.
Commure CEO Tanay Tandon on merging Athelas and Commure to automate healthcare administration with AI

Summary

Commure closed a $200 million funding round from General Catalyst, pushing its valuation to $6 billion. The company, led by CEO Tanay Tandon, operates AI workflow infrastructure across large hospital systems and private practices, serving roughly 250,000 physicians and nurses. Its product stack spans ambient AI documentation, revenue cycle automation, and claims processing — the full administrative layer that sits between a clinical encounter and a payment.

The company's origin is a merger. Tandon founded Athelas at Stanford, initially as a blood diagnostics company before it evolved into a mid-market operating system for physician practices. Commure began as an incubation inside General Catalyst, modeled loosely on Palantir's forward-deployed engineering approach but focused exclusively on healthcare. The two merged roughly 18 months ago, with Tandon taking over as CEO.

The General Catalyst Hospital Play

Commure is embedded in General Catalyst's acquisition of Summa Health, a hospital system based in Akron, Ohio with over 20 facilities — the first purchase of a U.S. hospital by a venture capital firm, approved by Ohio authorities. Commure serves as the de facto office of the CTO, with engineers deployed on-site working alongside Summa's IT, revenue cycle, and clinical leadership.

Tandon frames the Summa investment as a technology transformation thesis, not a private equity cost-cut play. U.S. hospital systems run on 1 to 3% operating margins and most fail. General Catalyst's bet is that LLMs can structurally improve those margins while also improving care quality.

Why Healthcare Administration Became So Bloated

The administrative burden in U.S. healthcare grew out of an arms race between insurers and providers. Post-Obamacare, payers steadily increased the friction required to approve claims, forcing health systems to add headcount to fight denials. UnitedHealth's market cap has grown roughly 12x since the ACA passed. The result is that large health systems now employ tens of thousands of people whose primary function is paperwork — filling out claims, calling insurers, contesting rejections.

Tandon argues LLMs shift that power dynamic back toward providers. The administrative workforce is, in his framing, white-collar labor about to become software — and healthcare concentrates more of that labor than any other sector in the U.S.

Product Strategy and Competitive Positioning

Commure's go-to-market mirrors Rippling and Ramp — enter with a wedge product, then expand into a compound platform. The two primary wedges are ambient AI, which automates clinical documentation and claim generation at the point of care, and back-office automation, which eliminates the manual claims and denial-management workflow entirely.

Tandon is explicit that point solutions in this space are structurally vulnerable. EMRs like Epic — which he values at roughly $100 billion — or platforms like Commure itself will absorb narrow tools over time. The goal is to own the CIO and CFO stack the way Ramp owns the CFO's payments and spend management layer.

Long-Term Ambition

Commure is targeting a $4 trillion industry. The end state Tandon describes is fully automated patient scheduling, intake, insurance verification, and instant post-appointment payment adjudication — eliminating the current 30 to 45 day claims settlement cycle. Achieving that requires new payment rails, not just software layered on existing infrastructure. The company is positioning itself as the entity that builds those rails, with EMR incumbents and payers both in its competitive crosshairs.